Stablepharma
50% of vaccines are wasted mostly due to failures in the global cold chain. Stablepharma aims to convert vaccines into fridge-free format using their patented process. With a POC for the Td vaccine done & fridge-free mRNA vaccines in development, they plan to grow their portfolio & go-to-market.
Past Raises
| 2022 | £3,000,000 | Closed |
We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.
If you'd like your events, opportunities and news listed here please join free as an organisation.